USPH Total Assets vs Long Term Debt Total Analysis

USPH Stock  USD 105.45  0.49  0.47%   
US Physicalrapy financial indicator trend analysis is much more than just breaking down US Physicalrapy prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether US Physicalrapy is a good investment. Please check the relationship between US Physicalrapy Total Assets and its Long Term Debt Total accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

Total Assets vs Long Term Debt Total

Total Assets vs Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of US Physicalrapy Total Assets account and Long Term Debt Total. At this time, the significance of the direction appears to have very strong relationship.
The correlation between US Physicalrapy's Total Assets and Long Term Debt Total is 0.88. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Long Term Debt Total in the same time period over historical financial statements of US Physicalrapy, assuming nothing else is changed. The correlation between historical values of US Physicalrapy's Total Assets and Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of US Physicalrapy are associated (or correlated) with its Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt Total has no effect on the direction of Total Assets i.e., US Physicalrapy's Total Assets and Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.88
Relationship DirectionPositive 
Relationship StrengthStrong

Total Assets

Total assets refers to the total amount of US Physicalrapy assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in US Physicalrapy books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Long Term Debt Total

Most indicators from US Physicalrapy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into US Physicalrapy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.As of now, US Physicalrapy's Enterprise Value Over EBITDA is increasing as compared to previous years. The US Physicalrapy's current Enterprise Value Multiple is estimated to increase to 17.58, while Selling General Administrative is projected to decrease to under 26.7 M.
 2021 2022 2023 2024 (projected)
Gross Profit117.2M112.0M112.0M117.6M
Total Revenue495.0M553.1M604.8M635.0M

US Physicalrapy fundamental ratios Correlations

0.890.960.980.930.760.90.770.821.00.820.950.70.690.80.980.950.920.95-0.410.960.930.99-0.40.540.55
0.890.950.90.830.570.890.560.710.890.710.880.730.470.710.820.780.810.76-0.240.750.830.85-0.480.60.61
0.960.950.930.960.750.890.70.740.970.740.90.670.580.690.940.920.840.91-0.390.890.960.93-0.380.510.52
0.980.90.930.870.630.890.670.890.960.890.930.750.70.880.930.910.970.89-0.260.910.880.95-0.460.60.61
0.930.830.960.870.850.840.770.680.950.680.840.580.60.590.950.940.780.95-0.490.920.990.91-0.290.420.43
0.760.570.750.630.850.740.920.320.810.320.730.470.60.280.840.780.480.89-0.840.850.820.81-0.260.350.36
0.90.890.890.890.840.740.750.580.910.580.970.880.690.640.860.780.750.82-0.440.820.80.89-0.70.790.8
0.770.560.70.670.770.920.750.40.80.40.770.550.650.40.840.730.560.87-0.850.860.730.82-0.380.460.46
0.820.710.740.890.680.320.580.40.761.00.680.490.580.950.770.810.970.710.040.760.720.76-0.20.340.35
1.00.890.970.960.950.810.910.80.760.760.950.70.680.750.980.940.880.96-0.480.960.940.99-0.40.540.55
0.820.710.740.890.680.320.580.41.00.760.680.490.580.950.770.810.970.710.040.760.720.76-0.20.340.35
0.950.880.90.930.840.730.970.770.680.950.680.860.730.740.90.830.840.87-0.40.870.820.94-0.640.740.75
0.70.730.670.750.580.470.880.550.490.70.490.860.690.590.630.550.650.58-0.20.590.530.67-0.90.980.98
0.690.470.580.70.60.60.690.650.580.680.580.730.690.610.720.740.690.72-0.30.750.610.71-0.590.630.64
0.80.710.690.880.590.280.640.40.950.750.950.740.590.610.730.720.950.650.040.720.630.77-0.320.450.46
0.980.820.940.930.950.840.860.840.770.980.770.90.630.720.730.970.870.99-0.530.990.960.98-0.330.470.48
0.950.780.920.910.940.780.780.730.810.940.810.830.550.740.720.970.880.96-0.390.960.970.93-0.240.380.39
0.920.810.840.970.780.480.750.560.970.880.970.840.650.690.950.870.880.82-0.10.860.810.88-0.360.50.51
0.950.760.910.890.950.890.820.870.710.960.710.870.580.720.650.990.960.82-0.60.990.950.96-0.290.420.43
-0.41-0.24-0.39-0.26-0.49-0.84-0.44-0.850.04-0.480.04-0.4-0.2-0.30.04-0.53-0.39-0.1-0.6-0.56-0.45-0.510.11-0.14-0.14
0.960.750.890.910.920.850.820.860.760.960.760.870.590.750.720.990.960.860.99-0.560.930.97-0.30.430.44
0.930.830.960.880.990.820.80.730.720.940.720.820.530.610.630.960.970.810.95-0.450.930.91-0.230.370.38
0.990.850.930.950.910.810.890.820.760.990.760.940.670.710.770.980.930.880.96-0.510.970.91-0.360.50.51
-0.4-0.48-0.38-0.46-0.29-0.26-0.7-0.38-0.2-0.4-0.2-0.64-0.9-0.59-0.32-0.33-0.24-0.36-0.290.11-0.3-0.23-0.36-0.97-0.97
0.540.60.510.60.420.350.790.460.340.540.340.740.980.630.450.470.380.50.42-0.140.430.370.5-0.971.0
0.550.610.520.610.430.360.80.460.350.550.350.750.980.640.460.480.390.510.43-0.140.440.380.51-0.971.0
Click cells to compare fundamentals

US Physicalrapy Account Relationship Matchups

US Physicalrapy fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets560.8M594.4M749.4M858.2M1.0B1.1B
Other Current Liab30.9M59.7M45.7M37.4M55.3M58.1M
Total Current Liabilities60.6M93.5M83.5M85.5M102.2M107.3M
Total Stockholder Equity240.3M276.2M295.6M315.8M476.2M500.0M
Property Plant And Equipment Net103.7M103.3M119.4M127.8M129.5M136.0M
Net Debt114.3M78.1M194.5M263.7M105.8M111.1M
Retained Earnings184.4M212.0M223.6M232.9M223.8M235.0M
Accounts Payable2.5M1.3M6.5M6.5M3.9M4.1M
Cash23.5M32.9M28.6M31.6M152.8M160.5M
Non Current Assets Total475.5M506.7M654.3M746.9M794.7M834.4M
Cash And Short Term Investments23.5M32.9M28.6M31.6M152.8M160.5M
Net Receivables56.1M50.9M62.4M68.6M71.8M75.4M
Common Stock Shares Outstanding12.8M12.8M12.9M13.0M14.2M12.9M
Liabilities And Stockholders Equity560.8M594.4M749.4M858.2M1.0B1.1B
Other Current Assets5.8M3.8M4.2M11.1M8.7M9.2M
Other Stockholder Equity55.8M64.0M71.9M78.7M249.5M261.9M
Total Liab181.4M184.4M297.0M373.6M375.8M394.6M
Property Plant And Equipment Gross103.7M103.3M97.9M208.0M214.4M225.1M
Total Current Assets85.4M87.6M95.2M111.3M233.4M245.0M
Short Long Term Debt Total137.8M111.0M223.1M295.3M258.6M271.5M
Non Currrent Assets Other1.5M1.5M(28.7M)(26.4M)158.0K165.9K
Non Current Liabilities Total120.8M90.9M213.5M288.1M273.7M287.3M
Short Term Debt27.2M32.4M31.3M41.6M42.9M45.1M
Intangible Assets52.6M56.3M86.4M108.8M109.7M115.2M
Good Will317.7M345.6M434.7M494.1M509.6M484.1M
Common Stock Total Equity148K149K150K151K173.7K144.3K
Common Stock149K150K151K152K172K147.0K
Other Assets1.5M14.1M1.6M1.6M1.9M2.1M
Long Term Debt50.4M16.6M117.6M175.8M139.0M145.9M
Property Plant Equipment22.1M21.7M119.4M127.8M146.9M154.3M
Other Liab10.2M12.3M21.7M34.3M39.5M41.5M
Net Tangible Assets7.7M6.6M(225.5M)(287.1M)(258.4M)(245.4M)
Noncontrolling Interest In Consolidated Entity930K1.4M1.5M1.6M1.4M1.3M
Retained Earnings Total Equity167.4M184.4M212.0M224.4M258.1M158.3M
Long Term Debt Total38.4M50.4M16.6M117.6M135.2M142.0M

Currently Active Assets on Macroaxis

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for USPH Stock analysis

When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is US Physicalrapy's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.19)
Dividend Share
1.73
Earnings Share
1.13
Revenue Per Share
41.242
Quarterly Revenue Growth
0.048
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.